LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC), (the “Company”) announced today that it has completed the acquisition of a proprietary technology for the treatment of diabetes and related ailments (the “Technology”) from the inventors of the Technology, Jean Arnett and…
Las Vegas, Nevada — Cell MedX Corp. (OTCQB:CMXC), (the “Company”) announces the formation of an Advisory Board with Dr. John Sanderson MD as its Chairman. Dr. Sanderson will be organizing the development team and protocols necessary to advance the development…